Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr-Jun;38(2):423-438.
doi: 10.1016/j.ijforecast.2020.08.004. Epub 2020 Aug 25.

Forecasting for COVID-19 has failed

Affiliations

Forecasting for COVID-19 has failed

John P A Ioannidis et al. Int J Forecast. 2022 Apr-Jun.

Abstract

Epidemic forecasting has a dubious track-record, and its failures became more prominent with COVID-19. Poor data input, wrong modeling assumptions, high sensitivity of estimates, lack of incorporation of epidemiological features, poor past evidence on effects of available interventions, lack of transparency, errors, lack of determinacy, consideration of only one or a few dimensions of the problem at hand, lack of expertise in crucial disciplines, groupthink and bandwagon effects, and selective reporting are some of the causes of these failures. Nevertheless, epidemic forecasting is unlikely to be abandoned. Some (but not all) of these problems can be fixed. Careful modeling of predictive distributions rather than focusing on point estimates, considering multiple dimensions of impact, and continuously reappraising models based on their validated performance may help. If extreme values are considered, extremes should be considered for the consequences of multiple dimensions of impact so as to continuously calibrate predictive insights and decision-making. When major decisions (e.g. draconian lockdowns) are based on forecasts, the harms (in terms of health, economy, and society at large) and the asymmetry of risks need to be approached in a holistic fashion, considering the totality of the evidence.

Keywords: Bayesian models; Bias; COVID-19; Forecasting; Hospital bed utilization; Mortality; SIR models; Validation.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Predictions for ICU beds made by the IHME models on March 31 for three states: California, New Jersey, and New York. For New York, the model initially over predicted enormously, and then it under predicted. For New Jersey, a neighboring state, the model started well but then it underpredicts, while for California it predicted a peak which never eventuated.
Fig. 2
Fig. 2
Performance of four data-driven models, IHME, YYG, UT, and LANL, used to predict COVID-19 death counts by state in the USA for the following day. That is, these were predictions made only 24 h in advance of the day in question. The Figure shows the percentage of times that a particular model’s prediction was within 10% of the ground truth by state. All models failed in terms of accuracy; for the majority of states, this figure was less than 20%.
Fig. 3
Fig. 3
Performance of the same models examined in Fig. 2 in terms of their uncertainty quantification. If a model assessment of uncertainty is accurate, then we would expect 95% of the ground truth values to fall within the 95% prediction interval. Only one of the 4 models (the UT model) approached this level of accuracy.
Fig. 4
Fig. 4
Snapshot from https://reichlab.io/covid19-forecast-hub/ (a very useful site that collates information and predictions from multiple forecasting models) as of 11.14 AM PT on June 3, 2020. Predictions for number of US deaths during week 27 (only 3 weeks downstream) with these 8 models ranged from 2419 to 11190, which is a 4.5-fold difference, and the spectrum of 95% confidence intervals ranged from fewer than 100 deaths to over 16,000 deaths, which is almost a 200-fold difference.
Fig. 5
Fig. 5
Population age-risk categories and COVID-19 deaths per age-risk category. The illustration uses estimates for a symptomatic case fatality rate of 0.05% in ages 0–49, 0.2% in ages 50–64, and 1.3% in ages 65 and over, similar to the CDC main planning scenario ( https://www.cdc.gov/coronavirus/2019-ncov/hcp/planning-scenarios.html). It also assumes that 50% of infections are asymptomatic in ages 0–49, 30% are asymptomatic in ages 50–64, and 10% are asymptomatic in ages 65 and over. Furthermore, it assumes that among people in nursing homes and related facilities (0.5% of the population in the USA), the infection fatality rate is 26%, as per Arons, Hatfield, Reddy, Kimball, James, et al. (2020). Finally, it assumes that some modest prognostic model is available where 4% of highest-risk people 0-49 years old explain 50% of the death risk in that category, the top 10% explains 70% of the deaths in the 50-64 years category, and the top 30% explains 90% of the risk in the 65 and above category. Based on available prognostic models (e.g. Williamson et al. (2020)), this prognostic classification should be readily attainable. As shown, <10% of the population is at high risk (shown with dense-colors and thus worth special protection and more aggressive measures), and these people account for >90% of the potential deaths. More than 90% of the population could possibly continue with non-disruptive measures as they account for only <10% of the total potential deaths.

References

    1. Actual Coronavirus Infections Vastly Undercounted, CDC. Data Shows - The New York Times, https://www.nytimes.com/2020/06/27/health/coronavirus-antibodies-asympto.... (Accessed 5 July 2020).
    1. AP counts: over 4500 virus patients sent to NY nursing homes (2020). Retrieved from https://apnews.com/5ebc0ad45b73a899efa81f098330204c. (Accessed 19 June 2020).
    1. Arons M.M., Hatfield K.M., Reddy S.C., Kimball A., James A., et al. Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility. New England Journal of Medicine. 2020;382:2081–2090. - PMC - PubMed
    1. Boccia S., Ricciardi W., Ioannidis J.P.A. What other countries can learn from Italy during the COVID-19 pandemic. JAMA Internal Medicine. 2020 doi: 10.1001/jamainternmed.2020.1447. - DOI - PubMed
    1. Chin V., Ioannidis J.P.A., Tanner M., Cripps S. 2020. Effects of non-pharmaceutical interventions on COVID-19: A Tale of Two Models. medRxiv. - DOI

LinkOut - more resources